Log In Get Started
Press Releases May 8, 2026 08:00 AM

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

Integra LifeSciences CFO to Present at BofA Securities 2026 Health Care Conference

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
IART

Integra LifeSciences Holdings Corporation announced that its CFO, Lea Knight, will present at the BofA Securities 2026 Health Care Conference on May 12, 2026. The presentation will be webcast live on the company's investor relations website. The event highlights Integra LifeSciences' ongoing engagement with investors and its leadership position in medical technology specializing in neurosurgery and tissue reconstruction.

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
IART
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Presentation by CFO Lea Knight scheduled for May 12, 2026, at BofA Securities Health Care Conference.
  • Live webcast available for investors and interested parties on Integra LifeSciences' website.
  • IntegraLifeSciences is a leading medical technology company focused on neurosurgery and tissue reconstruction with a portfolio of advanced, gold-standard technologies.

PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm PT.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.

About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com   

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com 

Integra LifeSciences Holdings Corporation


Risks

  • The presentation content may not include new or market-moving information, limiting impact on stock price.
  • Broader medical technology sector volatility could influence investor response irrespective of presentation.
  • Dependence on innovation and continued adoption of advanced technologies in specialized medical fields carries inherent business risks.

More from Press Releases

EVgo and Regency Expand National Partnership to Bring Fast Charging to More Retail Centers Across the U.S. Sep 9, 2026 ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026 Sep 9, 2026 Mount Logan Capital Inc. to Participate in the Lake Street Capital Markets 10th Annual Best Ideas Growth (BIG10) Conference Sep 9, 2026 Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2 Sep 9, 2026 SL Green Announces Sale of 110 Greene Street for $226 Million Sep 9, 2026